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Liver sinusoidal endothelial cells in disease – And for therapy?
Benjamin M. Stutchﬁeld, Stuart J. Forbes⇑
Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
COMMENTARY ON:
Role of differentiation of liver sinusoidal endothelial cells in
progression and regression of hepatic ﬁbrosis in rats. Xie G,
Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA,
Deleve LD. Gastroenterology. April 2012;142(4):918–927.e6.
Copyright (2012). Abstract reprinted by permission from the
American Gastroenterological Association.
http://www.ncbi.nlm.nih.gov/pubmed/22178212
Abstract: Background & Aims: Capillarization, characterized by
loss of differentiation of liver sinusoidal endothelial cells (LSECs), pre-
cedes the onset of hepatic ﬁbrosis. We investigated whether restora-
tion of LSEC differentiation would normalize crosstalk with activated
hepatic stellate cells (HSC) and thereby promote quiescence of HSC
and regression of ﬁbrosis.
Methods: Rat LSECs were cultured with inhibitors and/or agonists
and examined by scanning electron microscopy for fenestrae in sieve
plates. Cirrhosis was induced in rats using thioacetamide, followed
by administration of BAY 60-2770, an activator of soluble guanylate
cyclase (sGC). Fibrosis was assessed by Sirius red staining; expression
of a-smooth muscle actin was measured by immunoblot analysis.
Results: Maintenance of LSEC differentiation requires vascular
endothelial growth factor-A stimulation of nitric oxide-dependent
signaling (via sGC and cyclic guanosine monophosphate) and nitric
oxide-independent signaling. In rats with thioacetamide-induced cir-
rhosis, BAY 60-2770 accelerated the complete reversal of capillariza-
tion (restored differentiation of LSECs) without directly affecting
activation of HSCs or ﬁbrosis. Restoration of differentiation to LSECs
led to quiescence of HSCs and regression of ﬁbrosis in the absence of
further exposure to BAY 60-2770. Activation of sGC with BAY 60-
2770 prevented progression of cirrhosis, despite continued adminis-
tration of thioacetamide.
Conclusions: The state of LSEC differentiation plays a pivotal role in
HSC activation and the ﬁbrotic process.
And
Liver sinusoidal endothelial cell progenitor cells promote liver
regeneration in rats. Wang L, Wang X, Xie G, Wang L, Hill CK,
DeLeve LD. J Clin Invest. April 2 2012;122(4):1567–1573. Copy-
right (2012). Abstract reprinted by permission from the Ameri-
can Society for Clinical Investigation.
http://www.ncbi.nlm.nih.gov/pubmed/22406533
Abstract: The ability of the liver to regenerate is crucial to protect
liver function after injury and during chronic disease. Increases in
hepatocyte growth factor (HGF) in liver sinusoidal endothelial cells
(LSECs) are thought to drive liver regeneration. However, in contrast
to endothelial progenitor cells, mature LSECs express little HGF.
Therefore, we sought to establish in rats whether liver injury causes
BM LSEC progenitor cells to engraft in the liver and provide increased
levels of HGF and to examine the relative contribution of resident
and BM LSEC progenitors. LSEC label-retaining cells and progenitors
were identiﬁed in liver and LSEC progenitors in BM. BM LSEC progen-
itors did not contribute to normal LSEC turnover in the liver. How-
ever, after partial hepatectomy, BM LSEC progenitor proliferation
and mobilization to the circulation doubled. In the liver, one-quarter
of the LSECs were BM derived, and BM LSEC progenitors differenti-
ated into fenestrated LSECs. When irradiated rats underwent partial
hepatectomy, liver regeneration was compromised, but infusion of
LSEC progenitors rescued the defect. Further analysis revealed that
BM LSEC progenitors expressed substantially more HGF and were
more proliferative than resident LSEC progenitors after partial
hepatectomy. Resident LSEC progenitors within their niche may play
a smaller role in recovery from partial hepatectomy than BM LSEC
progenitors, but, when infused after injury, these progenitors
engrafted and expanded markedly over a 2-month period. In
conclusion, LSEC progenitor cells are present in liver and BM, and
recruitment of BM LSEC progenitors is necessary for normal liver
regeneration.
 2012 Published by Elsevier B.V. on behalf of the European
Association for the Study of the Liver.
The non-parenchymal cells of the liver have been receiving
greater prominence in the setting of injury and regeneration.
Hepatic stellate cells (HSCs) are the archetypal scar forming cells
of the liver but are also known for their pro-regenerative capabil-
ities and are able to secrete hepatocyte growth factor (HGF) and
promote liver regeneration [1]. Activated HSCs, myoﬁbroblasts
can also promote biliary regeneration from hepatic progenitor
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cells (HPCs) in chronic liver injury through the secretion of Notch
ligands [2]. Likewise hepatic macrophages are now recognized to
have an important role in both the promotion and regression of
liver ﬁbrosis [3]. In liver regeneration following partial hepatec-
tomy, macrophages facilitate regeneration through the secretion
of IL-6 [4] and in chronic liver injury promote the formation of
hepatocytes from HPCs through Wnt secretion [2]. In develop-
ment, endothelial cells have a role in organogenesis [5] and so
it is not surprising that liver sinusoidal endothelial cells (LSECs)
also have a role in liver regeneration. This was conﬁrmed in an
elegant paper from the group of Raﬁi who showed that LSECs
are essential for efﬁcient liver regeneration in a manner depen-
dent upon the DNA binding protein inhibitor Id1 in endothelial
progenitor cells [6]. Two recent interesting papers from the group
of Deleve have examined the role of LSECs and their precursors in
liver ﬁbrosis [7] and regeneration [8]. Pathological observations
in both humans and rodents have shown so called LSECs capillar-
ization in response to injury. This change occurs prior to the
development of ﬁbrosis and is characterized by loss of LSEC fene-
strations and the formation of a basement membrane. Xie et al.
demonstrate that maintenance of LSEC phenotype is dependent
upon vascular endothelial growth factor A (VEGF) driving both
nitric oxide-dependent signaling (via soluble guanylate cyclase
(sGC)) and nitric oxide-independent signaling [7]. The in vivo rel-
evance of these ﬁndings was shown in the thioacetamide model
of liver ﬁbrosis where the capillarization was reversed through
the use of a compound which activated sGC. This prevented pro-
gression of ﬁbrosis despite on-going injury and accelerated ﬁbro-
sis regression in recovery. This important study adds to the
collection of cells in the liver directly implicated in the formation
of liver ﬁbrosis and provides a further cellular target for antiﬁb-
rotic strategies, although, as this is a new area, it may be worth
considering whether capillarization has any positive roles. Whilst
morphological changes in LSECs are undoubtedly important in
the formation of liver ﬁbrosis, there are likely to be a wealth of
further signaling mechanisms at play also between LSECs, HSCs,
and even macrophages (Fig. 1).
Another feature of LSECs is that they respond to partial hepa-
tectomy by proliferating and secreting the hepatocyte mitogen
HGF. However, mature LSECs are typically low in HGF, while high
levels of HGF are seen in the more generic endothelial progenitor
cell and bone marrow-derived LSEC progenitors [8]. In the second
paper, the group use a rat model of partial hepatectomy to dem-
onstrate that LSEC progenitor cells arise from both the liver and
bone marrow (BM) to contribute to the regenerative response
[8]. These mobilized BM LSEC progenitors engrafted in the liver,
proliferated and were the highest secretors of HGF. At a func-
tional level, blocking BM LSEC progenitor mobilization by limb
irradiation reduced the rate of liver regeneration. This could be
reversed by injecting intravenously BM and liver-derived LSEC
progenitor cells, which could engraft the liver and form fenes-
trated LSECs. It is worth speculating whether this mobilization
of LSEC progenitors is related to the increased HGF expression
seen in lung, kidney, and spleen, contemporaneous to that in
the liver following partial hepatectomy. Whilst the HGF secreting
role of LSECs is indeed important, there are again likely to be
many other mechanisms to this pro-regenerative function.
These two studies open up a number of interesting, clinically
relevant questions, and possibilities. In the clinical setting, can
failure of effective liver regeneration result from hepatic LSEC
dysfunction or from a failure of mobilization of BM LSECs? Could
future liver remnant volume be enhanced in the context of portal
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Fig. 1. The endothelial cells of the hepatic sinusoid in health, ﬁbrosis, and regeneration. In the normal liver, LSECs are fenestrated and are ﬂanked by stellate cells and
Kupffer cells. In ﬁbrosis, fenestrae are lost and stellate cells are activated. In liver regeneration following hepatectomy, LSEC progenitors from the BM engraft the liver,
divide and express HGF strongly, which promotes hepatocyte proliferation. HGF, hepatocyte growth factor.
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vein embolization or following extended hepatectomy? Chemo-
therapy can injure LSECs, risking sinusoidal obstructive syndrome
and impaired regeneration following resection of hepatic metas-
tases [9]. Could modulation of intrahepatic LSECs promote liver
regeneration in this context? Nakamura et al. have tested endo-
thelial progenitor cells (EPCs) as a cellular therapy for ﬁbrosis.
Injections of syngeneic EPCs in a rat model of liver cirrhosis
reduced stellate cell activation, MMPs were increased and ﬁbrosis
was reduced, along with a stimulation of hepatocyte proliferation
[10]. Whilst promising, the clinical development of such cell ther-
apies may yet be challenging. If an autologous approach were
taken, it is not clear if therapeutically relevant numbers of LSEC
progenitors could be mobilized or isolated from patients with
clinically signiﬁcant liver dysfunction and indeed whether they
would be functionally competent. Whilst logistical hurdles
remain, the recent publications certainly suggest an area worthy
of further study.
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